CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$10.00

Daily low

$8.25

Price at open

$9.14

52 Week High

$14.60

52 Week Low

$1.10

Market cap

389.2M

Dividend yield

0.00%

Volume

4.8M

Avg. volume

10.0M

P/E ratio

-5.03

Candel Therapeutics News